Immunohistochemical Detection of the Wilms' Tumor Gene (WT1) in Epithelial Ovarian Tumors
- 1 April 2000
- journal article
- research article
- Published by Wolters Kluwer Health in International Journal of Gynecological Pathology
- Vol. 19 (2) , 158-163
- https://doi.org/10.1097/00004347-200004000-00010
Abstract
The Wilms' tumor gene WT1 plays multiple roles in the development of the genitourinary organs and Wilms' tumors. The aims of this study were to immunohistochemically evaluate WT1 expression in normal female genital tissues and in epithelial ovarian tumors and to look for correlations between WT1 expression and histologic subtypes and cell proliferation in epithelial ovarian tumors. In normal female genital organs, WT1 expression was recognized in ovarian surface epithelium, the lining of inclusion cysts, and tubal epithelium, but not in the cervical or endometrial epithelium. In epithelial ovarian tumors, serous tumors generally revealed a high WT1 expression. Among adenocarcinomas, serous carcinoma revealed a significantly higher WT1 expression than the other histologic subtypes. There were no significant correlations between the WT1 labeling index and the Ki-67 labeling index, and no significant difference in survival between those showing high and low WT1 expression among the malignant cases. These results suggest that WT1 expression may be related to cell differentiation, and that the histologic subtypes of epithelial ovarian carcinomas may differ considerably in their biological characteristics.Keywords
This publication has 24 references indexed in Scilit:
- Clear cell carcinoma has an expression pattern of cell cycle regulatory molecules that is unique among ovarian adenocarcinomasCancer, 1999
- Retinoblastoma Protein Expression in Ovarian Epithelial NeoplasmsGynecologic Oncology, 1998
- The combined evaluation ofp53 accumulation and of Ki-67 (MIBI) labelling index provides independent information on overall survival of ovarian carcinoma patientsAnnals of Oncology, 1997
- Expression of the p53 Induced Tumor Suppressor p21waf1/cip1 in Ovarian CarcinomasInternational Journal of Gynecological Pathology, 1997
- Increased expression of cyclin-dependent kinase inhibitor 2 (CDKN2A) gene product P16INK4A in ovarian cancer is associated with progression and unfavourable prognosisInternational Journal of Cancer, 1997
- p53 protein detected by immunohistochemistry as a prognostic factor in patients with epithelial overian carcinomaCancer, 1995
- Immunohistochemical analysis of p53 protein and 72 kDa heat shock protein (HSP72) expression in ovarian carcinomasVirchows Archiv, 1995
- Wilms' tumour gene and functionCurrent Opinion in Genetics & Development, 1993
- Cell growth regulation in epithelial ovarian cancerCancer, 1993
- Expression of the Wilms' tumor gene WT1 in the murine urogenital system.Genes & Development, 1991